189 related articles for article (PubMed ID: 26794303)
1. Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late-onset Pompe disease.
Johnson EM; Roberts M; Mozaffar T; Young P; Quartel A; Berger KI
Neuromuscul Disord; 2016 Feb; 26(2):136-45. PubMed ID: 26794303
[TBL] [Abstract][Full Text] [Related]
2. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
[TBL] [Abstract][Full Text] [Related]
3. Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease.
van der Beek NA; van Capelle CI; van der Velden-van Etten KI; Hop WC; van den Berg B; Reuser AJ; van Doorn PA; van der Ploeg AT; Stam H
Mol Genet Metab; 2011; 104(1-2):129-36. PubMed ID: 21763167
[TBL] [Abstract][Full Text] [Related]
4. Progression from respiratory dysfunction to failure in late-onset Pompe disease.
Berger KI; Chan Y; Rom WN; Oppenheimer BW; Goldring RM
Neuromuscul Disord; 2016 Aug; 26(8):481-9. PubMed ID: 27297666
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.
Wenninger S; Greckl E; Babačić H; Stahl K; Schoser B
J Neurol; 2019 Jan; 266(1):133-147. PubMed ID: 30430231
[TBL] [Abstract][Full Text] [Related]
6. Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis.
Berger KI; Kanters S; Jansen JP; Stewart A; Sparks S; Haack KA; Bolzani A; Siliman G; Hamed A
J Neurol; 2019 Sep; 266(9):2312-2321. PubMed ID: 31187190
[TBL] [Abstract][Full Text] [Related]
7. Utility of maximum inspiratory and expiratory pressures as a screening method for respiratory insufficiency in slowly progressive neuromuscular disorders.
Wenninger S; Stahl K; Wirner C; Einvag K; Thiele S; Walter MC; Schoser B
Neuromuscul Disord; 2020 Aug; 30(8):640-648. PubMed ID: 32690350
[TBL] [Abstract][Full Text] [Related]
8. Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining.
Jones HN; Crisp KD; Robey RR; Case LE; Kravitz RM; Kishnani PS
Mol Genet Metab; 2016 Feb; 117(2):120-8. PubMed ID: 26381077
[TBL] [Abstract][Full Text] [Related]
9. Effects of respiratory muscle training (RMT) in children with infantile-onset Pompe disease and respiratory muscle weakness.
Jones HN; Crisp KD; Moss T; Strollo K; Robey R; Sank J; Canfield M; Case LE; Mahler L; Kravitz RM; Kishnani PS
J Pediatr Rehabil Med; 2014; 7(3):255-65. PubMed ID: 25260508
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease.
Ruggeri P; Lo Monaco L; Musumeci O; Tavilla G; Gaeta M; Caramori G; Toscano A
Neurol Sci; 2020 Aug; 41(8):2175-2184. PubMed ID: 32162165
[TBL] [Abstract][Full Text] [Related]
11. The Maximal Expiratory-to-Inspiratory Pressure Ratio and Supine Vital Capacity as Screening Tests for Diaphragm Dysfunction.
Koo P; Oyieng'o DO; Gartman EJ; Sethi JM; Eaton CB; McCool FD
Lung; 2017 Feb; 195(1):29-35. PubMed ID: 27803970
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary outcome measures in long-term survivors of infantile Pompe disease on enzyme replacement therapy: A case series.
ElMallah MK; Desai AK; Nading EB; DeArmey S; Kravitz RM; Kishnani PS
Pediatr Pulmonol; 2020 Mar; 55(3):674-681. PubMed ID: 31899940
[TBL] [Abstract][Full Text] [Related]
13. Diaphragm Pacing as a Rehabilitative Tool for Patients With Pompe Disease Who Are Ventilator-Dependent: Case Series.
Smith BK; Fuller DD; Martin AD; Lottenberg L; Islam S; Lawson LA; Onders RP; Byrne BJ
Phys Ther; 2016 May; 96(5):696-703. PubMed ID: 26893511
[TBL] [Abstract][Full Text] [Related]
14. Inspiratory Muscle Training in Late-Onset Pompe Disease: The Effects on Pulmonary Function Tests, Quality of Life, and Sleep Quality.
Aslan GK; Huseyinsinoglu BE; Oflazer P; Gurses N; Kiyan E
Lung; 2016 Aug; 194(4):555-61. PubMed ID: 27106274
[TBL] [Abstract][Full Text] [Related]
15. Blunted Hypercapnic Respiratory Drive Response in Subjects With Late-Onset Pompe Disease.
De Vito EL; Monteiro SG; Aruj PK
Respir Care; 2016 Jul; 61(7):930-5. PubMed ID: 27006351
[TBL] [Abstract][Full Text] [Related]
16. 3D analysis of the chest wall motion for monitoring late-onset Pompe disease patients.
Meric H; Falaize L; Pradon D; Orlikowski D; Prigent H; Lofaso F
Neuromuscul Disord; 2016 Feb; 26(2):146-52. PubMed ID: 26711305
[TBL] [Abstract][Full Text] [Related]
17. Observational clinical study of 22 adult-onset Pompe disease patients undergoing enzyme replacement therapy over 5years.
Stepien KM; Hendriksz CJ; Roberts M; Sharma R
Mol Genet Metab; 2016 Apr; 117(4):413-8. PubMed ID: 26873529
[TBL] [Abstract][Full Text] [Related]
18. Altered activation of the diaphragm in late-onset Pompe disease.
Smith BK; Corti M; Martin AD; Fuller DD; Byrne BJ
Respir Physiol Neurobiol; 2016 Feb; 222():11-5. PubMed ID: 26612101
[TBL] [Abstract][Full Text] [Related]
19. Respiratory failure in Pompe disease: treatment with noninvasive ventilation.
Mellies U; Stehling F; Dohna-Schwake C; Ragette R; Teschler H; Voit T
Neurology; 2005 Apr; 64(8):1465-7. PubMed ID: 15851748
[TBL] [Abstract][Full Text] [Related]
20. Maximal Respiratory Muscle Strength and Vital Capacity in Children With Early Onset Scoliosis.
Redding G; Mayer OH; White K; Bompadre V; Emerson J; Krengel W; Campbell R
Spine (Phila Pa 1976); 2017 Dec; 42(23):1799-1804. PubMed ID: 28858191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
